These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1829366)

  • 1. Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users.
    Mientjes GH; Miedema F; van Ameijden EJ; van den Hoek AA; Schellekens PT; Roos MT; Coutinho RA
    AIDS; 1991 Jan; 5(1):35-41. PubMed ID: 1829366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
    Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
    Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone.
    Klimas NG; Blaney NT; Morgan RO; Chitwood D; Milles K; Lee H; Fletcher MA
    Am J Med; 1991 Feb; 90(2):163-70. PubMed ID: 1671730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol use and T-lymphocyte subsets among injection drug users with HIV-1 infection: a prospective analysis.
    Crum RM; Galai N; Cohn S; Celentano DD; Vlahov D
    Alcohol Clin Exp Res; 1996 Apr; 20(2):364-71. PubMed ID: 8730231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users.
    Lyles CM; Margolick JB; Astemborski J; Graham NM; Anthony JC; Hoover DR; Vlahov D
    AIDS; 1997 Aug; 11(10):1255-62. PubMed ID: 9256944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users.
    Margolick JB; Muñoz A; Vlahov D; Astemborski J; Solomon L; He XY; Nelson KE; Saah AJ
    Arch Intern Med; 1994 Apr; 154(8):869-75. PubMed ID: 7908795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bispecific antibody-directed antitumor activity of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus interleukin 2.
    Nishimura T; Nakamura Y; Takeuchi Y; Gao XH; Tokuda Y; Okumura K; Habu S
    Jpn J Cancer Res; 1991 Nov; 82(11):1207-10. PubMed ID: 1836455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.
    Rezza G; Titti F; Pezzotti P; Sernicola L; Lo Caputo S; Angarano G; Lazzarin A; Sinicco A; Rossi GB; Verani P
    J Biol Regul Homeost Agents; 1992; 6(1):15-20. PubMed ID: 1359736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in laboratory values in HIV infection by sex, race, and risk group.
    Gorter RW; Vranizan KM; Osmond DH; Moss AR
    AIDS; 1992 Nov; 6(11):1341-7. PubMed ID: 1361747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users.
    Carballo-Diéguez A; Sahs J; Goetz R; el Sadr W; Sorell S; Gorman J
    Am J Drug Alcohol Abuse; 1994 Aug; 20(3):317-29. PubMed ID: 7977217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses to HIV-1 antigens are higher in HIV-1(+) intravenous drug users than in HIV-1(+) homosexuals.
    Jiang JD; Bekesi GJ
    Biomed Pharmacother; 2001 Jul; 55(6):313-5. PubMed ID: 11478582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineages.
    Janossy G; Borthwick N; Lomnitzer R; Medina E; Squire SB; Phillips AN; Lipman M; Johnson MA; Lee C; Bofill M
    AIDS; 1993 May; 7(5):613-24. PubMed ID: 8318170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
    Margolick JB; Muñoz A; Vlahov D; Solomon L; Astemborski J; Cohn S; Nelson KE
    JAMA; 1992 Mar; 267(12):1631-6. PubMed ID: 1347321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group.
    Markowitz N; Hansen NI; Wilcosky TC; Hopewell PC; Glassroth J; Kvale PA; Mangura BT; Osmond D; Wallace JM; Rosen MJ; Reichman LB
    Ann Intern Med; 1993 Aug; 119(3):185-93. PubMed ID: 8100692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection.
    Boaz MJ; Waters A; Murad S; Easterbrook PJ; Vyakarnam A
    J Immunol; 2002 Dec; 169(11):6376-85. PubMed ID: 12444145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
    Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
    Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men.
    Galai N; Vlahov D; Margolick JB; Chen K; Graham NM; Muñoz A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):66-74. PubMed ID: 8548349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users.
    Iorio AM; Alatri A; Francisci D; Preziosi R; Neri M; Donatelli I; Castrucci MR; Biasio LR; Tascini C; Iapoce R; Pierucci P; Baldelli F
    Vaccine; 1997 Jan; 15(1):97-102. PubMed ID: 9041673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HIV infection and T-lymphocyte behavior: results of a study in Palermo].
    Cangelosi C; Giardina RA; Pecoraro G; Marcianò R; Vitale MG; Gullotti A; Caronia F; Spanò C
    Ann Ig; 1989; 1(1-2):45-50. PubMed ID: 2483080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users.
    Carbone J; Gil J; Benito JM; Navarro J; Muñóz-Fernández A; Bartolomé J; Zabay JM; López F; Fernández-Cruz E
    AIDS; 2000 Dec; 14(18):2823-9. PubMed ID: 11153663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.